Abstract
Research by other investigators has established that insulin-like growth factor-1 receptor (IGF-1R) is a key oncological target, and that derivatives of 1, 3-disubstituted-imidazo[1,5-α] pyrazine are potent IGF-1R inhibitors. In this paper, we report on our three-dimensional quantitative structure activity relationship (3D-QSAR) studies for this series of compounds. We validated the 3D-QSAR models by the comparison of two major alignment schemes, namely, ligand-based (LB) and receptor-guided (RG) alignment schemes. The latter scheme yielded better 3D-QSAR models for both comparative molecular field analysis (CoMFA) ( q2 =0.53, r2 = 0.95) and comparative molecular similarity indices analysis (CoMSIA) ( q2 =0.51, r2 =0.86). We submit that this might arise from the more accurate inhibitor alignment that results from using the structural information of the active site. We conclude that the receptor-guided 3D-QSAR may be helpful to design more potent IGF-1R inhibitors, as well as to understand their binding affinity with the receptor. Copyright © 2008 M. Muddassar et al.
Cite
CITATION STYLE
Muddassar, M., Pasha, F. A., Chung, H. W., Yoo, K. H., Oh, C. H., & Cho, S. J. (2008). Receptor guided 3D-QSAR: A useful approach for designing of IGF-1R inhibitors. Journal of Biomedicine and Biotechnology, 2008(1). https://doi.org/10.1155/2008/837653
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.